CN Patent

CN105899205A — 预防进展成2型糖尿病的方法

Assigned to Vivus LLC · Expires 2016-08-24 · 10y expired

What this patent protects

本发明提供用于延迟或预防患有前驱糖尿病和代谢综合征的个体进展成2型糖尿病的组合物和方法。

USPTO Abstract

本发明提供用于延迟或预防患有前驱糖尿病和代谢综合征的个体进展成2型糖尿病的组合物和方法。

Drugs covered by this patent

solriamfetol-hydrochloride (SOLRIAMFETOL HYDROCHLORIDE)

Patent Metadata

Patent number: CN105899205A
Jurisdiction: CN
Classification: —
Expires: 2016-08-24
Drug substance claim: No
Drug product claim: No
Assignee: Vivus LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.